Inventor · disambiguated record
Christophe Claude Parsy
Also filed as: PARSY CHRISTOPHE · PARSY CHRISTOPHE C · PARSY CHRISTOPHE CLAUDE
24 granted patents·10 pending applications·338 citations·filing 2008–2021
96Inventor score
Files withIDENIX PHARMACEUTICALS INC15IDENIX PHARMACEUTICALS LLC6PARSY CHRISTOPHE CLAUDE3BOGEN STEPHANE2MERCK SHARP & DOHME2
Top patents by PatentIndex Score
34 records- 0198US8507460B2Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Aug 13, 2013·67 cites·20 claims
- 0296US9309275B23′-deoxy nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·28 cites·24 claims
- 0396US9109001B23′,5′-cyclic phosphoramidate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·60 cites·28 claims
- 0495US8362068B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·66 cites·53 claims
- 0594US9296778B23′,5′-cyclic phosphate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·37 cites·21 claims
- 0688US9353100B2Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infectionsPARSY CHRISTOPHE CLAUDE·Filed 2012·Granted May 31, 2016·8 cites·37 claims
- 0788US8481748B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 9, 2013·4 cites·42 claims
- 0887US8377962B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·14 cites·93 claims
- 0986US8309737B2Phosphinate ruthenium complexesPARSY CHRISTOPHE CLAUDE·Filed 2010·Granted Nov 13, 2012·4 cites·38 claims
- 1084US11730748B2Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseasesMSD INT GMBH·Filed 2020·Granted Aug 22, 2023·1 cites·11 claims
- 1184US9187496B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·8 cites·45 claims
- 1284US8993595B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 31, 2015·8 cites·96 claims
- 1383US10815264B2Nucleotides for the treatment of cancerIDENIX PHARMACEUTICALS LLC·Filed 2016·Granted Oct 27, 2020·2 cites·10 claims
- 1483US8765966B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·2 cites·42 claims
- 1582US9284307B2Macrocyclic serine protease inhibitorsPARSY CHRISTOPHE CLAUDE·Filed 2010·Granted Mar 15, 2016·8 cites·18 claims
- 1682US8003659B2Macrocyclic serine protease inhibitorsINDENIX PHARMACEUTICALS INC·Filed 2009·Granted Aug 23, 2011·10 cites·189 claims
- 1779US10030044B2Nucleotides for the treatment of liver cancerIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jul 24, 2018·4 cites·46 claims
- 1876US8410313B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Apr 2, 2013·1 cites·20 claims
- 1974US8362018B2Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infectionsBIOFOCUS DPI LTD·Filed 2008·Granted Jan 29, 2013·5 cites·17 claims
- 2071US10766917B2Nucleotides for the treatment of cancerIDENIX PHARMACEUTICALS LLC·Filed 2016·Granted Sep 8, 2020·1 cites·7 claims
- 2168US9115095B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Aug 25, 2015·0 cites·17 claims
- 2264US2022040214A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2356US10513534B22′-chloro nucleoside analogs for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Dec 24, 2019·0 cites·60 claims
- 2454US2014271547A1Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcvIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2552US11040975B2Carbocyclic nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Jun 22, 2021·0 cites·8 claims
- 2652US10231986B2Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCVCENTRE NAT RECH SCIENT·Filed 2015·Granted Mar 19, 2019·0 cites·31 claims
- 2752US2019365788A1Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseasesIDENIX PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 2852US2009047244A1Macrocyclic serine protease inhibitors iIDENIX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2947US2020179428A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Application pending·0 cites
- 3047US2016002281A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 3142US2016083413A12'-chloro nucleoside analogs for hcv infectionIDENIX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3240US2019192548A1Use of cyclic phosphate substituted nucleoside derivativesfor the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Application pending·0 cites
- 3338US2012252721A1Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitorDOUSSON CYRIL B·Filed 2012·Application pending·0 cites
- 3431US2017101431A1Nucleoside derivatives for the treatment of cancerDOUSSON CYRIL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christophe Claude Parsy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →